Bridge to Life Gains FDA 510(k) Clearance for Innovative Solutions
Today marks a significant achievement for Bridge to Life, Ltd., a recognized leader in the field of organ preservation and perfusion. The company has successfully secured FDA 510(k) clearance for its multi-sourced Belzer UW and MPS organ preservation solutions. This important clearance now positions Belzer MPS to cover all abdominal organs, creating a pivotal development within transplantation.
Ensuring Consistent Supply and Customer Satisfaction
Bridge to Life's organ preservation solutions play a crucial role in the daily operations of Organ Procurement Organizations (OPOs) and transplant centers globally. To guarantee consistent availability, the company has implemented a robust global inventory buffer of at least 60 days. Additionally, they've formed exclusive supplier agreements across various key regions. This robust strategy not only enhances resilience across supply chains but also facilitates the delivery of tailored solutions to meet the diverse and evolving requirements of healthcare providers.
Commitment to Global Regulatory Standards
Alongside its clearance efforts in the U.S., Bridge to Life is actively working toward receiving CE Marks for its groundbreaking preservation solutions, with expectations for approvals soon. This commitment emphasizes the company's dedication to ensuring worldwide accessibility while adhering to stringent regulatory standards.
A Transition from Distributor to Industry Pioneer
Over the years, Bridge to Life has significantly evolved, beginning with exclusive rights to the Belzer UW and MPS from the University of Wisconsin. Their expansion now includes the EasiSlush brand, establishing a portfolio that healthcare professionals trust for over a decade. Bridge to Life goes beyond merely providing solutions; it is continuously advancing in engineering and next-generation product development, distinguishing itself as a leader in both foundational preservation and cutting-edge perfusion technologies.
About Bridge to Life Ltd.
Bridge to Life Ltd. is regarded as a frontrunner in organ preservation solutions, renowned for their high-quality products such as Belzer UW, EasiSlush, and the VitaSmart Hypothermic Oxygenated Perfusion System. Their unwavering commitment to innovation, product excellence, and accessibility enables partnerships with leading transplant centers and organ procurement organizations across the globe.
For further insights into their offerings including the Belzer UW Cold Storage Solution and the Belzer MPS Machine Perfusion Solution, interested parties are encouraged to visit the Bridge to Life website.
Note: VitaSmart is CE Marked and accessible in various international markets, although it remains investigational in the U.S., currently awaiting FDA review and clearance.
Frequently Asked Questions
What solutions has Bridge to Life received FDA clearance for?
Bridge to Life received FDA 510(k) clearance for its Belzer UW and MPS organ preservation solutions.
How does Bridge to Life ensure supply continuity?
The company maintains a minimum 60-day global inventory buffer and has exclusive supplier agreements to ensure consistent availability.
What is the significance of the expanded labeling for Belzer MPS?
It allows the Belzer MPS solution to be applicable for all abdominal organs, enhancing its usability in transplantation.
What regulatory approvals is Bridge to Life pursuing?
Bridge to Life is actively pursuing CE Marks for its solutions, with approvals expected in the coming years.
How does Bridge to Life stand out in the market?
The company offers both foundational preservation solutions and innovative products, positioning itself as a comprehensive provider in the organ preservation sector.
